Decoding Alzheimer’s disease:
trial designs, biomarker breakthroughs, and redefining patient-first strategies
About this webinar
Alzheimer’s disease (AD) presents ongoing challenges for sponsors seeking earlier identification and more efficient therapeutic evaluation. Join experts from across IQVIA as they share the latest advances in AD clinical research. From early patient identification to leveraging breakthrough biomarkers and global site networks, the featured speakers will discuss actionable strategies for optimizing central nervous system (CNS) trials.
Discover how innovative approaches and operational expertise can help biotech and emerging biopharma sponsors lead therapeutic innovation, accelerate recruitment, overcome trial challenges and stay ahead in a rapidly evolving market.
Register for this webinar to learn how Alzheimer’s disease trial strategies can improve design, recruitment and decision-making.
Who should attend
This webinar is intended for C-suite and clinical development/operations executives in small, mid and large pharma and biotech companies.
What you will learn
- The impacts of biomarkers and diagnostics for earlier, more precise detection
- Best practices in patient recruitment, site management and global trial execution for operational excellence
- Novel trial designs and patient identification, transforming early intervention strategies in Alzheimer’s research for biotech
Featured Speakers
Joanna Pulawska, PhD
Joanna Pulawska oversees Global Operations and Strategic Delivery for clinical trials in CNS and CVRM therapeutic areas at IQVIA Biotech. With over 20 years of experience in global clinical research, she has held senior leadership roles across therapeutic areas, including oncology, neurology, immunology and cardiovascular diseases. Joanna earned her PhD in Molecular Biology from the University of Toronto and holds an MSc from the University of Warsaw.
Marek Bieniek, MD
Dr. Marek Bieniek is a board-certified Neurologist with over 25 years of experience in neurology practice and more than 10 years in Medical Affairs in the pharmaceutical industry. His research focuses on MRI imaging in understanding MS pathology. At IQVIA’s CNS Center of Excellence, he supports the development of innovative therapies for neurological disorders.
Anu Chaudhary, PhD
Anu Chaudhary, PhD, is the Global Technical Lead for Immunology at IQVIA Laboratories, overseeing assay development and execution for clinical testing. With over 28 years of experience in research, assay development and drug discovery, Anu holds a PhD from SUNY-Stony Brook and completed postdoctoral studies at Harvard Medical School and Fred Hutchinson Cancer Research Center. Her career spans roles in the pharmaceutical industry, Los Alamos National Laboratory and the University of Washington School of Medicine.
Partner for this event
IQVIA Biotech
IQVIA Biotech is a biotech-specialized CRO delivering flexible clinical development solutions for biotech and emerging biopharma companies. Our clinical solutions are built on 25+ years of unmatched experience with therapeutically aligned expertise, uniquely designed to deliver full-service solutions on a global scale. Learn more at iqviabiotech.com.
Related webinars
More from IQVIA.
Accelerate Your Study: Harnessing AI and Automation for Rapid Study Start-up
Centralize to Modernize: A Stepwise Path to Agile Clinical Operations
Redefining Clinical Project Management: The Strategic Power of FSP Models
Safety & Regulatory Compliance Predictions For 2026: Unlock Safety & Regulatory Trends With IQVIA
Advancing AI in Study Startup
Accelerating CSR Timelines: Applying Real-Time Data, Governed Standards and Expert Oversight
From Insight to Impact: Delivering Trials Patients Want to Join
Designing Innovative Trials: Navigating Dose Optimization in Oncology Combinations
Accelerating Clinical Research with Master Protocols: Challenges and Benefits to Complex Trial Designs
Integrating Patient-Centric Sample Collection into Clinical Trials
Leveraging AI in Clinical Development to Innovate with Greater Confidence
Driving Efficiency and Quality in Clinical Trials Through AI & Innovation